Some OTC drugs linked to increased chance of dementia: study
The risk of dementia is said to be high when the so-called anticholinergic drugs are taken in high doses over several years. Anticholinergics are a class of drug
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have granted paediatric clinical trial waivers to Shanton Pharma for its lead candidate SAP-001, easing the drug’s regulatory paths to approval.
The randomized double-blind, event-driven superiority trial is designed to examine the benefits of the once-daily, oral Factor Xa Inhibitor, rivaroxaban in these patients. Around 7,000 patients will be
The agreement establishes the collaboration and structure to enable better scientific understanding of the medicinal use of cannabis to treat diseases such as Parkinson’s, epilepsy, Alzheimer’s, brain damage,
The expanded agreements will allow Gilead’s India-based partners to manufacture GS-5816 and the single tablet regimen of sofosbuvir/GS-5816, once approved, for distribution in 91 developing countries, which together